Assessing the Risk of Hemolysis in Cardiovascular Devices

This webinar delves into the practical application of Computational Fluid Dynamics (CFD) in cardiovascular device development, focusing on mitigating hemolysis risk. Hemolysis, the breakdown of red blood cells, poses a significant patient safety concern. CFD provides a solution to this problem, allowing for accurate simulations of fluid flow and shear stress.

Learn the capabilities of Ansys CFD for streamlining product design, reducing development costs, and improving patient outcomes. We'll demonstrate how CFD supports efficient design alterations and optimization strategies to reduce hemolysis.

Diving deeper, this webinar will walk you through the comprehensive process of using Ansys CFD. This includes the selection of a suitable blood model, defining device geometry and boundary conditions, and conducting sensitive analyses. With these insights, you'll grasp how CFD can inform device enhancement strategies and affect product performance and patient health.

Join us for a 30-minute discussion on the emerging trends, potential hurdles, and promising opportunities in hemolysis analysis for cardiovascular devices. This will be immediately followed by a Q&A session where we welcome your thoughts and queries.

1. Introduction to hemolysis in cardiovascular devices and its impact on patient health

2. Overview of Computational Fluid Dynamics (CFD) and its applications in hemolysis analysis

3. Selection of an appropriate blood model for CFD simulations

4. Representation of device geometry and boundary conditions in CFD simulations

5. Sensitivity analyses to identify the most important factors influencing hemolysis

6. Design modifications and optimization strategies based on CFD results to minimize hemolysis risk

7. Discussion of future directions and challenges in the field of hemolysis analysis using CFD

8. Q&A

Assessing the Risk of Hemolysis in Cardiovascular Devices

Wednesday, June 28, 2023

12pm - 1pm (PST)

Register